Skip to content
10-Q

Quarterly Report

Eton Pharmaceuticals, Inc. ETON

0001437749-25-033619

← back to feed
Filed
Nov 6, 2025 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2025 · Nov 5, 2025 26.82M sh
Shares Diluted Q3 2025 · Sep 30, 2025 26.89M sh
Shares Diluted Q3 2025 · Sep 30, 2025 26.89M sh
Shares Diluted restated Q3 2025 · Sep 30, 2024 26.55M sh
Shares Diluted restated Q3 2025 · Sep 30, 2024 25.81M sh
Capex Q3 2025 · Sep 30, 2025 $284K
Capex Q3 2025 · Sep 30, 2024 $14K
Operating Cash Flow Q3 2025 · Sep 30, 2025 $22.08M
Operating Cash Flow Q3 2025 · Sep 30, 2024 $1.73M
Long Term Debt Q3 2025 · Sep 30, 2025 $27.59M
Long Term Debt Q3 2025 · Dec 31, 2024 $29.81M
Short Term Debt Q3 2025 · Sep 30, 2025 $2.78M
Short Term Debt Q3 2025 · Dec 31, 2024 $0
Cash And Equivalents Q3 2025 · Sep 30, 2025 $37.12M
Cash And Equivalents Q3 2025 · Dec 31, 2024 $14.94M
Stockholders Equity Q3 2025 · Sep 30, 2025 $23.13M
Stockholders Equity Q3 2025 · Jun 30, 2025 $23.96M
Stockholders Equity Q3 2025 · Dec 31, 2024 $24.43M
Stockholders Equity Q3 2025 · Sep 30, 2024 $15.98M
Stockholders Equity Q3 2025 · Jun 30, 2024 $13.46M
Stockholders Equity Q3 2025 · Dec 31, 2023 $15.48M
Current Liabilities Q3 2025 · Sep 30, 2025 $44.18M
Current Liabilities Q3 2025 · Dec 31, 2024 $19.95M
Total Liabilities Q3 2025 · Sep 30, 2025 $81.38M
Total Liabilities Q3 2025 · Dec 31, 2024 $51.7M
Current Assets Q3 2025 · Sep 30, 2025 $72M
Current Assets Q3 2025 · Dec 31, 2024 $41.02M
Total Assets Q3 2025 · Sep 30, 2025 $104.51M
Total Assets Q3 2025 · Dec 31, 2024 $76.12M
Eps Diluted Q3 2025 · Sep 30, 2025 −$0.07
Eps Diluted Q3 2025 · Sep 30, 2025 −$0.23
Eps Diluted Q3 2025 · Sep 30, 2024 $0.02
Eps Diluted Q3 2025 · Sep 30, 2024 −$0.12
Eps Basic Q3 2025 · Sep 30, 2025 −$0.07
Eps Basic Q3 2025 · Sep 30, 2025 −$0.23
Eps Basic Q3 2025 · Sep 30, 2024 $0.02
Eps Basic Q3 2025 · Sep 30, 2024 −$0.12
Sga Expense Q3 2025 · Sep 30, 2025 $8.11M
Sga Expense Q3 2025 · Sep 30, 2025 $26.96M
Sga Expense Q3 2025 · Sep 30, 2024 $5.29M
Sga Expense Q3 2025 · Sep 30, 2024 $16.04M
Rd Expense Q3 2025 · Sep 30, 2025 $1.11M
Rd Expense Q3 2025 · Sep 30, 2025 $5.99M
Rd Expense Q3 2025 · Sep 30, 2024 $505K
Rd Expense Q3 2025 · Sep 30, 2024 $4.13M
Net Income Q3 2025 · Sep 30, 2025 −$1.93M
Net Income Q3 2025 · Sep 30, 2025 −$6.08M
Net Income Q3 2025 · Sep 30, 2024 $627K
Net Income Q3 2025 · Sep 30, 2024 −$3.23M
Operating Income Q3 2025 · Sep 30, 2025 −$1.36M
Operating Income Q3 2025 · Sep 30, 2025 −$3.31M
Operating Income Q3 2025 · Sep 30, 2024 $509K
Operating Income Q3 2025 · Sep 30, 2024 −$3.23M
Gross Profit Q3 2025 · Sep 30, 2025 $7.86M
Gross Profit Q3 2025 · Sep 30, 2025 $29.64M
Gross Profit Q3 2025 · Sep 30, 2024 $6.3M
Gross Profit Q3 2025 · Sep 30, 2024 $16.94M
Cost Of Revenue Q3 2025 · Sep 30, 2025 $14.6M
Cost Of Revenue Q3 2025 · Sep 30, 2025 $29.03M
Cost Of Revenue Q3 2025 · Sep 30, 2024 $4.02M
Cost Of Revenue Q3 2025 · Sep 30, 2024 $10.43M
Revenue Q3 2025 · Sep 30, 2025 $22.46M
Revenue Q3 2025 · Sep 30, 2025 $58.67M
Revenue Q3 2025 · Sep 30, 2024 $10.32M
Revenue Q3 2025 · Sep 30, 2024 $27.36M